SOLTF Projected Dividend Yield

Ord/Nxera Pharma Co Ltd ( OTCBB : SOLTF )

Sosei Group is a biopharmaceutical holding company. Co. through its subsidiaries, is engaged in the discover and development of drugs for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. Co. establishes product pipeline by utilizing its platform technologies, GPCR structure-based drug design platform technology and peptide platform technologies. Co.'s development and commercialization partners, including Pfizer, NEUROCRINE BIOSCIENCES, GSK, Genentech, Takeda, abbvie, Lilly, sanofi, PepptiDream, metrion biosciences, PHARMENABLE, InveniAI, verily, KALLYOPE, TEMPERO BIO, and Orexia Therapeutics.

20 YEAR PERFORMANCE RESULTS

SOLTF Dividend History Detail
SOLTF Dividend News
SOLTF Competitors News
# of Shares: 0 Closing Price: 6.95 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor